Labiotech.eu

News and Trends 20 Nov 2017

British and German Scientists Chuck Proteins in the Trash to Uncover their Function

Trim-Away removes a protein to uncover its true function, which will support disease research and potentially the development of new therapies. Scientists at the Medical Research Council in the UK and the Max Planck Institute in Germany have discovered Trim-Away, a new technique that can remove a protein from a cell so that its true function can […]

November 20, 2017 - 3 minutesmins - By Alex Dale

News and Trends 20 Nov 2017

After Failed Trial, French Biotech Gets Good News for its Peanut Allergy Therapy

DBV Technologies has positive safety data supporting the approval of a treatment for peanut allergy in children, though its efficacy is uncertain. DBV Technologies saw its stock go down by 45% last month after releasing Phase III data for ViaSkin Peanut, a treatment delivered via a skin patch aimed at reducing peanut allergy in children aged […]

November 20, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Interview 20 Nov 2017

Thinking of Leaving Academia? Read this VC Partner’s Story

Anne Portwich, Partner at venture capital firm LSP, told me about her career path and how to succeed in the life science industry. Anne Portwich became the first woman partner at LSP in 2011. The fund has raised more than $1B since it was founded more than 25 years ago, and the cash goes mainly to […]

November 20, 2017 - 9 minutesmins - By Evelyn Warner

More News! 18 Nov 2017

Bacterial Art Starts a Debate on Money and International Borders

We have been told over and over that bacteria are everywhere around us, especially on your smartphone screen. But most of us haven’t stopped to reflect on the fact — and consequences — of bacteria being all over our money. A scientific study by the New York University called the Dirty Money Project revealed in […]

November 18, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 17 Nov 2017

Welcome to the Blockbuster Club, Genmab!

Genmab has achieved $1B sales in the US of its blood cancer drug, Darzalex, setting a great example for other European biotechs to follow. Genmab has officially joined the elite of the biotech world by achieving $1B (€850M) in sales of its drug for multiple myeloma, Darzalex. The biotech will now receive milestone payments of $50M (€42M) […]

November 17, 2017 - 3 minutesmins - By Alex Dale

News and Trends 17 Nov 2017

British Biotech Gets Ready to Launch a New Antibiotic Drug to Fight Resistance

Update (17/11/2017): Motif Bio will raise up to $20M (€17M) in the form of a loan from US firm Hercules Capital. The funds will be used to fund the pre-commercialization stage of iclaprim, a new antibiotic that is expected to be launched in the US in 2019. Originally published on 04/10/2017 Iclaprim is a new antibiotic […]

November 17, 2017 - 3 minutesmins - By Alex Dale

News and Trends 16 Nov 2017

German Cancer Sensor Raises the Alarm and Puts the Fire Out

No need to call the fire brigade! The University of Dresden’s cancer sensor spots a mutation to p53, the most important cancer gene, and kills the cell. Researchers at the University of Dresden, Germany, have developed a molecular sensor that detects a mutation in tumor protein p53 – implicated in 50% of cancers – and kills […]

November 16, 2017 - 3 minutesmins - By Alex Dale

hummingbird diagnostics cancer alzheimer parkinson

News and Trends 16 Nov 2017

German Diagnostics Firm Tackles Early Detection of Cancer, Alzheimer’s and Parkinson’s

Hummingbird Diagnostics has teamed up with Saarland University to develop molecular diagnostics that can detect serious diseases early using blood samples. Based in Heidelberg, Germany, Hummingbird Diagnostics develops early diagnostics in multiple disease areas, ranging from cancer to cardiovascular and neurodegenerative disease. Its technology is based in the detection of miRNA, molecules that are involved […]

November 16, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 16 Nov 2017

Anti-Parasite Drug May Help to Treat Prostate Cancer, Say Norwegian Scientists

Researchers in Norway have found that a drug used to kill parasites like tapeworms can slow the growth of prostate and colon cancer cells. A group from the University of Bergen have been testing hundreds of drugs to see how they affect cancer cells. They have now found a drug taken to treat intestinal parasites, Giardia and […]

November 16, 2017 - 3 minutesmins - By Alex Dale

News and Trends 16 Nov 2017

German Scientists Test Out New HIV Vaccine Combinations in Animals

Scientists from the German Primate Center have investigated the impact of the delivery route and order of components on the success of an HIV vaccine. With more than 36 million people infected with the human immunodeficiency virus (HIV) and a further 2.4 million infected each year, something needs to be done. Researchers from the German […]

November 16, 2017 - 3 minutesmins - By Alex Dale

Interview 16 Nov 2017

Waking Up the Immune System with Luc Dochez, CEO of Tusk Therapeutics

Tusk Therapeutics is developing antibodies to ignite the immune system response against cancer. We spoke with CEO Luc Dochez about Tusk and the oncology field. Tusk Therapeutics, based just north of London, focuses on therapeutic antibodies to boost the immune system in the fight against cancer. The company has been developing a number of candidates […]

November 16, 2017 - 6 minutesmins - By Alex Dale

News and Trends 15 Nov 2017

New British Biotech Receives £3M to Develop Small Molecules that Fight Cancer

NeoPhore, has received investment from Sixth Element Capital to develop small molecules that stimulate the immune system against cancer. Sixth Element Capital has invested £3M (€3.3M) in NeoPhore, a new spin-out from PhoreMost – a drug discovery company based in Cambridge, UK. NeoPhore has been set up to explore small molecules that could be used to stimulate […]

November 15, 2017 - 1 minutemin - By Alex Dale

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

British and German Scientists Chuck Proteins in the Trash to Uncover their Function

After Failed Trial, French Biotech Gets Good News for its Peanut Allergy Therapy

Thinking of Leaving Academia? Read this VC Partner’s Story

Bacterial Art Starts a Debate on Money and International Borders

Welcome to the Blockbuster Club, Genmab!

British Biotech Gets Ready to Launch a New Antibiotic Drug to Fight Resistance

German Cancer Sensor Raises the Alarm and Puts the Fire Out

German Diagnostics Firm Tackles Early Detection of Cancer, Alzheimer’s and Parkinson’s

Anti-Parasite Drug May Help to Treat Prostate Cancer, Say Norwegian Scientists

German Scientists Test Out New HIV Vaccine Combinations in Animals

Waking Up the Immune System with Luc Dochez, CEO of Tusk Therapeutics

New British Biotech Receives £3M to Develop Small Molecules that Fight Cancer

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!